Centene to offer buyouts to some employees
Sheldon Cooper | Lightrocket | Getty Images Centene said it offered buyouts to some employees on Monday, as…
CVS Health executives on reducing healthcare’s biggest pain points
Nikolas Kokovlis | Nurphoto | Getty Images A version of this article first appeared in CNBC’s Healthy Returns…
Space race comes for pharma: Why drug development is heading to orbit
The highly anticipated SpaceX mega-IPO is part of a space frenzy that is moving beyond satellite connectivity, launch…
Novo Nordisk, Eli Lilly roll out obesity pills, prepare for Medicare coverage
Novo Nordisk and Eli Lilly took their GLP-1 pill battle to the preeminent obesity meeting this weekend as…
Weight loss drug maker stock sinks 25% as safety data spooks investors
Shares of weight loss drug maker Zealand Pharma plummeted as much as 26% on Monday after new data…
CVS restores Zepbound coverage, adds Eli Lilly’s obesity pill Foundayo
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on…
Eli Lilly makes a new push into vaccines – here’s what to know
The Eli Lilly logo appears on the company’s office in San Diego, California, Nov. 21, 2025. Mike Blake…
White House adds generic drugs to direct-to-consumer TrumpRx site
President Donald Trump speaks to introduce the TrumpRx website in the South Court Auditorium of the White House…
Biogen Alzheimer’s drug moves to late stage trial
A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Biogen plans to advance an experimental drug for…
Novo Nordisk releases new high-dose Wegovy data
A Wegovy injection pen shown in Waterbury, Vermont, April 28, 2025. Shelby Knowles | Bloomberg | Getty Images…
Novo Nordisk faces Ozempic generics in Canada
Ozempic is medicine for adults with type 2 diabetes that along with diet and exercise may improve blood…
How Barrière aims to disrupt the supplement industry
The supplement industry has seen booming demand over the past few years as consumers increasingly focus on health…